散发性与C9orf72相关肌萎缩侧索硬化中神经递质定义的退变模式:GABA能、5-羟色胺能、阿片、谷氨酸能、内源性大麻素及小胶质细胞系统的易感性——对治疗开发的意义
一项纳入258名参与者的神经影像学研究,评估神经退变与神经递质表达分布的拓扑关联,按遗传背景将患者分为散发性和C9orf72六核苷酸重复扩增携带者。散发性ALS退变与GABA-A受体α5选择性成分、5-羟色胺1a受体和κ阿片受体表达图谱存在拓扑关联;C9orf72相关ALS还易感谷氨酸能、内源性大麻素回路并涉及小胶质细胞介导的神经炎症。多时间点纵向分析显示局灶体积丢失与神经递质表达的时间关联动态变化,但高脱落率妨碍确定性纵向推断。
要点
- 散发性ALS退变与GABA-A受体α5、5-羟色胺1a受体和κ阿片受体表达图谱存在拓扑关联。
- C9orf72相关ALS还易感谷氨酸能、内源性大麻素回路,并涉及小胶质细胞介导的神经炎症。
- 纵向分析中与去甲肾上腺素转运体和GABAa5的空间关联增加,但高脱落率妨碍确定性纵向推断。
核心结论
- 数据提示散发性ALS中GABA能、5-羟色胺能和κ阿片介导网络存在优先易感性。
- C9orf72相关ALS中谷氨酸能、内源性大麻素回路也易感,并涉及小胶质细胞介导的神经炎症。
- 神经递质-受体关联的全面评估不仅提供ALS病理生理过程的学术见解,还可能为靶向治疗开发策略提供信息。
研究设计与样本
- 大型神经影像学研究,纳入258名参与者。
- 按遗传背景将患者分为散发性ALS和C9orf72六核苷酸重复扩增携带者。
- 评估萎缩模式与拓扑神经递质受体分布之间的解剖关联。
- 在连续4个时间点上全面评估横断面和纵向趋势。
主要发现
- 散发性ALS的神经退变与GABA-A受体α5选择性成分、5-羟色胺1a受体和κ阿片受体表达图谱存在拓扑关联。
- C9orf72 GGGGCC六核苷酸重复扩增患者的神经元丢失除上述网络外,还易感谷氨酸能、内源性大麻素和小胶质细胞系统。
- 多时间点纵向分析显示局灶体积丢失与神经递质表达之间呈动态时间关联,与去甲肾上腺素转运体和GABAa5的空间关联增加,但高脱落率妨碍确定性纵向推断。
临床怎么用
- 作者认为,神经递质-受体关联的全面评估可能为靶向治疗开发策略提供信息。
局限性
- 高脱落率妨碍确定性纵向推断。
- 原文为横断面和纵向趋势评估,纵向关联受高脱落率限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective Amyotrophic lateral sclerosis (ALS) has a markedly distinctive clinical and neuroradiological signature, with the preferential involvement of specific brain networks and the apparent sparing of others. The molecular underpinnings of the strikingly selective anatomical vulnerability have not been fully elucidated to date despite the potential therapeutic relevance of characterizing neurotransmitter receptor-defined susceptibility to degeneration. Methods A large neuroimaging study was undertaken with 258 participants to systematically evaluate topological associations between neurodegeneration and neurotransmitter expression distributions. Patients were stratified based on their genetic profile into sporadic and C90rf72 hexanucleotide repeat expansion carriers. Anatomical associations were evaluated between patterns of atrophy and topological neurotransmitter receptor distributions. Cross-sectional and longitudinal trends were comprehensively evaluated over 4 consecutive timepoints. Results Our analyses reveal topological associations between neurodegeneration in sporadic ALS and GABA-A receptor α5-selective component (GABAa5), serotonin 1a receptor, and kappa opioid receptor expression maps. In addition to these networks, neuronal loss in patients with GGGGCC hexanucleotide repeat expansions exhibit predilection to glutamatergic, endocannabinoid, and microglial systems. Our multi-timepoint longitudinal analyses reveal dynamic temporal associations between focal volume loss and neurotransmitter expression with increasing spatial associations with noradrenaline transporter and GABAa5, but high attrition rates preclude definite longitudinal inferences. Interpretation Our data suggest the preferential vulnerability of GABAergic, serotonergic, kappa opioid mediated networks in sporadic ALS. In C9orf72-assocaited ALS, glutamatergic, endocannabinoid circuits are also susceptible and microglia-mediated neuroinflammation is also implicated. The comprehensive evaluation of neurotransmitter-receptor associations not only offer academic insights regarding pathophysiological processes in ALS, but may inform targeted therapy development strategies. ANN NEUROL 2026;100:948–961
引用
- Annals of Neurology:Neurotransmitter‐Defined Degeneration Patterns in Sporadic and C9orf72‐Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic, Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems—Implications for Therapy Development
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。